These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21030232)

  • 1. Excessive costs of COPD in ever-smokers. A longitudinal community study.
    Nielsen R; Johannessen A; Omenaas ER; Bakke PS; Askildsen JE; Gulsvik A
    Respir Med; 2011 Mar; 105(3):485-93. PubMed ID: 21030232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economics of COPD: literature review and experiences from field work.
    Nielsen R; Klemmetsby M; Gulsvik A
    Clin Respir J; 2008 Oct; 2 Suppl 1():104-10. PubMed ID: 20298358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Productive cough is an independent risk factor for the development of COPD in former smokers.
    Yamane T; Hattori N; Kitahara Y; Haruta Y; Sasaki H; Yokoyama A; Kohno N
    Respirology; 2010 Feb; 15(2):313-8. PubMed ID: 20070589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations].
    Jahnz-Rózyk K; Targowski T; From S; Płusa T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Walk-in spirometry pilot project for discovering of early chronic obstructive pulmonary disease].
    Løkke A; Christensen LB; Fuglsang C
    Ugeskr Laeger; 2009 Oct; 171(43):3083-8. PubMed ID: 19852895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between disease severity, smoking index age and direct costs of hospital treatment of COPD exacerbations].
    Targowski T; Jahnz-Rózyk K; From S; Płusa T
    Pneumonol Alergol Pol; 2005; 73(1):32-5. PubMed ID: 16539181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.
    Lindberg A; Bjerg A; Rönmark E; Larsson LG; Lundbäck B
    Respir Med; 2006 Feb; 100(2):264-72. PubMed ID: 15975774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dynamic population model of disease progression in COPD.
    Hoogendoorn M; Rutten-van Mölken MP; Hoogenveen RT; van Genugten ML; Buist AS; Wouters EF; Feenstra TL
    Eur Respir J; 2005 Aug; 26(2):223-33. PubMed ID: 16055869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
    Stav D; Raz M
    Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.
    Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S
    Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
    Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
    Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of COPD exacerbations in the emergency department and inpatient setting.
    Dalal AA; Shah M; D'Souza AO; Rane P
    Respir Med; 2011 Mar; 105(3):454-60. PubMed ID: 20869226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD.
    Stratelis G; Mölstad S; Jakobsson P; Zetterström O
    Scand J Prim Health Care; 2006 Sep; 24(3):133-9. PubMed ID: 16923621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The occurrence of chronic obstructive pulmonary disease (COPD) in cigarette smoking families.
    Kałucka S
    Przegl Lek; 2006; 63(10):848-57. PubMed ID: 17288170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study.
    Castillo D; Guayta R; Giner J; Burgos F; Capdevila C; Soriano JB; Barau M; Casan P;
    Respir Med; 2009 Jun; 103(6):839-45. PubMed ID: 19200706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of COPD exacerbations: a university hospital--based study in Greece.
    Geitona M; Hatzikou M; Steiropoulos P; Alexopoulos EC; Bouros D
    Respir Med; 2011 Mar; 105(3):402-9. PubMed ID: 20970310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
    Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
    J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of a questionnaire as a screening test for chronic obstructive pulmonary disease among the Bangkok elderly.
    Maranetra N; Chuaychoo B; Lertakyamanee J; Naruman C; Chierakul N; Dejsomritrutai W; Nana A; Thamlikitkul W; Suthamsmai T; Saengkaew S; Sreelum W; Aksornin M; Dechapol A; Reungcham C
    J Med Assoc Thai; 2003 Nov; 86(11):1033-41. PubMed ID: 14696785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.